GLP-1 and GIP receptor activation produces gastrointestinal effects (nausea, reduced appetite) that are dose-dependent
The Points system is genuinely flexible and easy to live with, the app and community are polished, and adding a real medical arm means it can now offer GLP-1 therapy rather than just behavior change
Medicare Part D traditionally excludes weight management
Triglycerides back in range
Linking context with reward: a functional circuit from hippocampal CA3 to ventral tegmental area
In additional secondary endpoints, retatrutide reduced known markers of cardiovascular risk, including non-HDL cholesterol, triglycerides, and high-sensitivity C-reactive protein (hsCRP), and at the highest dose lowered systolic blood pressure by 14.0 mmHg, using the efficacy estimand